A Randomized Phase II Study of Two Different Schedules of RAD001C in Patients With Recurrent/Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 29 Nov 2016
At a glance
- Drugs Everolimus (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 18 Jan 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 18 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History